KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Dividends Paid - Common (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.85%
Dec 31, 2025 0.08%
Sep 30, 2025 0.16%
Jun 30, 2025 0.08%
Mar 31, 2025 6.14%
Dec 31, 2024 -0.41%
Sep 30, 2024 0.08%
Jun 30, 2024 0.08%
Mar 31, 2024 5.96%
Dec 31, 2023 0.00%
Sep 30, 2023 0.09%
Jun 30, 2023 0.18%
Mar 31, 2023 9.33%
Dec 31, 2022 0.19%
Sep 30, 2022 0.00%
Jun 30, 2022 -3.89%
Mar 31, 2022 9.09%
Dec 31, 2021 -0.90%
Sep 30, 2021 -0.89%
Jun 30, 2021 -0.79%
Mar 31, 2021 9.01%
Dec 31, 2020 -0.43%
Sep 30, 2020 -0.64%
Jun 30, 2020 -0.32%
Mar 31, 2020 9.88%
Dec 31, 2019 -0.92%
Sep 30, 2019 -1.36%
Jun 30, 2019 -2.33%
Mar 31, 2019 7.26%
Dec 31, 2018 -1.29%
Sep 30, 2018 -1.62%
Jun 30, 2018 -9.04%
Mar 31, 2018 14.03%
Dec 31, 2017 -0.48%
Sep 30, 2017 -0.95%
Jun 30, 2017 -0.12%
Mar 31, 2017 13.39%
Dec 31, 2016 0.00%
Sep 30, 2016 -0.66%
Jun 30, 2016 0.00%
Mar 31, 2016 26.17%
Dec 31, 2015 -0.50%
Sep 30, 2015 -0.50%
Jun 30, 2015 0.50%
Mar 31, 2015 29.09%
Dec 31, 2014 0.00%
Sep 30, 2014 0.22%
Jun 30, 2014 0.65%
Mar 31, 2014 29.94%
Dec 31, 2013 0.00%
Sep 30, 2013 0.00%
Jun 30, 2013 0.28%
Mar 31, 2013 28.83%
Dec 31, 2012 -1.79%
Sep 30, 2012 -0.36%
Jun 30, 2012 -1.75%
Mar 31, 2012 16.33%
Dec 31, 2011 -3.92%